Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
- 31 August 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 14 (9), 901-908
- https://doi.org/10.1016/s1470-2045(13)70277-8
Abstract
No abstract availableKeywords
Funding Information
- Amgen
This publication has 23 references indexed in Scilit:
- Benign bone tumors—recent developmentsSeminars in Diagnostic Pathology, 2011
- Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of BoneBMC Cancer, 2010
- Morphological and immunophenotypic features of primary and metastatic giant cell tumour of boneVirchows Archiv, 2009
- Giant cell tumour of boneCurrent Opinion in Oncology, 2009
- Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western IndiaAnnals of Diagnostic Pathology, 2008
- RANK Expression as a Cell Surface Marker of Human Osteoclast Precursors in Peripheral Blood, Bone Marrow, and Giant Cell Tumors of BoneJournal of Bone and Mineral Research, 2006
- Giant Cell Tumor of BoneAmerican Journal of Clinical Oncology, 2006
- GIANT-CELL TUMOUR OF BONEThe Journal of Bone and Joint Surgery. British volume, 2004
- Gene Expression of Osteoprotegerin Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Giant Cell Tumor of BoneThe American Journal of Pathology, 2000
- Human giant cell tumors of bone identification and characterization of cell types.JCI Insight, 1987